Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Reliability of a Single-region Tumor Sample for Evaluating the Immune Tumor Microenvironment of Hepatocellular Carcinoma Tumors

ABSTRACT: Reliability of a Single-region Tumor Sample for Evaluating the Immune Tumor Microenvironment of Hepatocellular Carcinoma Tumors

PROVIDER: PRJNA563216 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR10054030_1.fastq.gz	Fastqsanger.gz
	SRR10054030_2.fastq.gz	Fastqsanger.gz
	SRR10054031_1.fastq.gz	Fastqsanger.gz
	SRR10054031_2.fastq.gz	Fastqsanger.gz
	SRR10054032_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 82

Similar Datasets

Reliability of a Single-region Tumor Sample for Evaluating the Immune Tumor Microenvironment of Hepatocellular Carcinoma Tumors

Project description:Heterogeneity in immune microenvironment within a tumor may pose a barrier to evaluate immune tumor microenvironment by using a single-region tumor sample, such as a single tumor biopsy. Our study using both immunohistochemical and transcriptomic analyses showed that a single-region sample is reliable for evaluation of immune tumor microenvironment in 60-70% of HCC patients.

2020-04-17 | GSE136711 | GEO

Evaluating cell culture reliability in pediatric brain tumor primary cells through DNA methylation profiling

Project description:Evaluating cell culture reliability in pediatric brain tumor primary cells through DNA methylation profiling

| PRJNA937655 | ENA

Tumor immune microenvironment difference primary and metastatic hepatocellular carcinoma

Project description:Tumor immune microenvironment difference primary and metastatic hepatocellular carcinoma

| PRJNA591784 | ENA

Evaluating cell culture reliability in pediatric brain tumor primary cells through DNA methylation profiling

Project description:In vitro models of pediatric brain tumors (pBT) are tools instrumental for better understanding the mechanisms contributing to oncogenesis and testing new therapies; and thus, ideally, they should recapitulate the original tumor. We applied DNA methylation (DNAm) and copy number variation (CNV) profiling to characterize 241 pBT samples, including 155 tumors and 86 pBT-derived cell cultures, and considering serum vs serum-free conditions, late vs early passages, and dimensionality (2D vs 3D cultures). We performed a t-SNE classification and identified differentially methylated regions in tumors compared to cell models. Early cell cultures recapitulate the original tumor, but serum media and 2D culturing were demonstrated to significant contribute to the divergence of DNAm profiles from the parental ones. All divergent cells clustered together acquiring a common deregulated epigenetic signature, suggesting a shared selective pressure. In conclusion, DNAm and CNV are informative tools that should be used to assess the recapitulation of pBT-cells from parental tumors.

2024-03-25 | GSE225810 | GEO

Immune Editing Roles of SIGLEC15 in Tumor Microenvironment of Hepatocellular Carcinoma

Project description:Immune Editing Roles of SIGLEC15 in Tumor Microenvironment of Hepatocellular Carcinoma

| PRJNA903797 | ENA

Single-Cell Transcriptomic Profiling of the Tumor Microenvironment in Treatment-Naive Hepatocellular Carcinoma Patients

Project description:This study provides high-resolution single-cell RNA sequencing (scRNA-seq) data of tumor tissues from 12 treatment-naive hepatocellular carcinoma (HCC) patients. The dataset captures the transcriptomic profiles of diverse cell populations, including tumor cells, immune cells (e.g., T cells, B cells, macrophages), and stromal cells, revealing cellular heterogeneity and key gene expression signatures within the HCC tumor microenvironment (TME). This resource is critical for investigating HCC pathogenesis, identifying therapeutic targets, and developing immunotherapeutic strategies.

2025-03-03 | GSE290925 | GEO

Proteomic characterization of human hepatocellular carcinoma (HCC) tumor biopsies

Project description:We analyzed the proteome of tumor and matched non-tumor biopsies from 51 treatment-naive Hepatocellular carcinoma (HCC) patients by DIA (SWATH). Thereby we aim to find subgroups of patients characterized by specific pathway activation. Furthermore, we aim to find novel factors involved in HCC development and novel biomarkers.

2022-03-14 | PXD025705 | Pride

The Tumor Microenvironment Shapes Innate Lymphoid Cells in Patients with Hepatocellular Carcinoma

Project description:The Tumor Microenvironment Shapes Innate Lymphoid Cells in Patients with Hepatocellular Carcinoma

| PRJNA744903 | ENA

The Tumor Microenvironment Shapes Innate Lymphoid Cells in Patients with Hepatocellular Carcinoma

Project description:The Tumor Microenvironment Shapes Innate Lymphoid Cells in Patients with Hepatocellular Carcinoma

| PRJNA745080 | ENA

Phospho-proteomic characterization of human hepatocellular carcinoma (HCC) tumor biopsies

Project description:We analyzed the phospho-proteome of tumor and matched non-tumor biopsies from 51 treatment-naive Hepatocellular carcinoma (HCC) patients by label-free DDA. Thereby we aim to find subgroups of patients characterized by specific pathway activation. Furthermore, we aim to find novel factors involved in HCC development and novel biomarkers.

2022-03-14 | PXD025836 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data